Biomay is an integrated GMP contract development and manufacturing organisation (CDMO) for end-to-end manufacturing of mRNA. Biomay´s services also include the supply of GMP-grade circular or linear template DNA used for in-vitro transcription of mRNA. For analytical testing of mRNA and template DNA, a comprehensive set of GMP-conform quality control methods is established. In addition, Biomay offers aseptic filling services for drug substance and drug product, at final batch volumes ranging from 100 mg until 50 gram scale. The company´s facilities and systems are inspected by the U.S. FDA. Biomay operates two independent manufacturing sites located in Vienna, Austria.